FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:19-25 July 4, 2002 Number 1 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Roberts, D. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Previous data have demonstrated associations between thrombophilia polymorphisms in pregnant women and an increased risk of intrauterine growth restriction in their offspring, but this finding remains uncertain.

Methods We performed a hospital-based case–control study and a family-based study including 493 newborns with intrauterine growth restriction (defined by birth weight below the 10th percentile for gestational age and sex according to Canadian norms) and 472 controls (with birth weight at or above the 10th percentile). We determined the presence or absence in newborns and their parents of the following polymorphisms: methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C, factor V Leiden G1691A, and prothrombin G20210A. Mothers were interviewed to obtain information on other risk factors for intrauterine growth restriction.

Results The risk of intrauterine growth restriction was not increased among mothers carrying a polymorphism associated with thrombophilia. In the case–control study, the odds ratios associated with two copies of the variant, after adjustment for newborn genotype and other risk factors, were 1.55 for MTHFR C677T (95 percent confidence interval, 0.83 to 2.90) and 0.49 for MTHFR A1298C (95 percent confidence interval, 0.25 to 0.93); heterozygotes for factor V Leiden had an odds ratio of 1.18 (95 percent confidence interval, 0.54 to 2.55), and heterozygotes for prothrombin G20210A had an odds ratio of 0.92 (95 percent confidence interval, 0.36 to 2.35). These polymorphisms in the newborn were not associated with an increased risk. Newborns who were homozygous for the MTHFR C677T variant had a decreased risk of intrauterine growth restriction (odds ratio after adjustment for mother's genotype and other confounders, 0.52 [95 percent confidence interval, 0.29 to 0.94]). The results of the family-based study supported those of the case–control study.

Conclusions Our findings do not indicate that there are associations between maternal or newborn polymorphisms associated with thrombophilia and an increased risk of intrauterine growth restriction.

Source Information

From the Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, Montreal (C.I.-R.); the Research Centre (C.I.-R., G.-E.R., W.V.Y., J.C.F.-F.), the Division of Hematology and Oncology (G.E.-R., W.V.Y.), and the Department of Obstetrics (R.G.), Centre Hospitalier Universitaire Mère–Enfant, Hôpital Sainte-Justine, Université de Montréal, Montreal; INSERM Unité 535, Génétique Epidémiologique et Structure des Populations Humaines, Le Kremlin Bicêtre, Paris (E.G., M.G.); and the National Institute of Environmental Health Sciences, Research Triangle Park, N.C. (C.W.).

Address reprint requests to Dr. Infante-Rivard at the Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, 1130 Pine Ave. W., Montreal, QC H3A 1A3, Canada, or at claire.infante-rivard{at}mcgill.ca.

Full Text of this Article

Related Letters:

Thrombophilia Polymorphisms and Intrauterine Growth Restriction
Kupferminc M. J., Many A., Lessing J. B., Grandone E., Margaglione M., Infante-Rivard C., Rivard G.-E., Gauthier R.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:1530-1531, Nov 7, 2002. Correspondence

This article has been cited by other articles:

• Dubois, J. MD MSc, Rypens, F. MD, Garel, L. MD, David, M. MD, Lacroix, J. MD, Gauvin, F. MD MSc (2007). Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents. CMAJ 177: 1185-1190 [Abstract] [Full Text]  
• Tamura, T., Picciano, M. F. (2006). Folate and human reproduction. Am. J. Clin. Nutr. 83: 993-1016 [Abstract] [Full Text]  
• Nurk, E., Tell, G.S., Refsum, H., Ueland, P.M., Vollset, S.E. (2006). Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 99: 289-298 [Abstract] [Full Text]  
• Kistner, E. O., Infante-Rivard, C., Weinberg, C. R. (2006). A Method for Using Incomplete Triads to Test Maternally Mediated Genetic Effects and Parent-of-Origin Effects in Relation to a Quantitative Trait. Am J Epidemiol 163: 255-261 [Abstract] [Full Text]  
• Bockenstedt, P. L. (2006). Management of Hereditary Hypercoagulable Disorders. ASH Education Book 2006: 444-449 [Abstract] [Full Text]  
• Infante-Rivard, C., Weinberg, C. R. (2005). Parent-of-Origin Transmission of Thrombophilic Alleles to Intrauterine Growth-Restricted Newborns and Transmission-Ratio Distortion in Unaffected Newborns. Am J Epidemiol 162: 891-897 [Abstract] [Full Text]  
• Li, D., Pickell, L., Liu, Y., Wu, Q., Cohn, J. S, Rozen, R. (2005). Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am. J. Clin. Nutr. 82: 188-195 [Abstract] [Full Text]  
• Bates, S. M., Greer, I. A., Hirsh, J., Ginsberg, J. S. (2004). Use of Antithrombotic Agents During Pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 627S-644S [Abstract] [Full Text]  
• Brenner, B. (2004). Clinical management of thrombophilia-related placental vascular complications. Blood 103: 4003-4009 [Abstract] [Full Text]  
• Tempfer, C. B., Jirecek, S., Riener, E. K., Zeisler, H., Denschlag, D., Hefler, L., Husslein, P. W. (2004). Polymorphisms of Thrombophilic and Vasoactive Genes and Severe Preeclampsia: A Pilot Study. Reproductive Sciences 11: 227-231 [Abstract]  
• Hefler, L., Jirecek, S., Heim, K., Grimm, C., Antensteiner, G., Zeillinger, R., Husslein, P., Tempfer, C. (2004). Genetic Polymorphisms Associated With Thrombophilia and Vascular Disease in Women With Unexplained Late Intrauterine Fetal Death: A Multicenter Study. Reproductive Sciences 11: 42-44 [Abstract]  
• Cattaneo, M. (2003). Homocysteine and the Risk of Intrauterine Growth Retardation. Clin. Chem. 49: 1432-1433 [Full Text]  
• Infante-Rivard, C., Rivard, G.-E., Gauthier, R., Theoret, Y. (2003). Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction. Clin. Chem. 49: 1476-1482 [Abstract] [Full Text]  
• Wilcken, B, Bamforth, F, Li, Z, Zhu, H, Ritvanen, A, Redlund, M, Stoll, C, Alembik, Y, Dott, B, Czeizel, A E, Gelman-Kohan, Z, Scarano, G, Bianca, S, Ettore, G, Tenconi, R, Bellato, S, Scala, I, Mutchinick, O M, Lopez, M A, de Walle, H, Hofstra, R, Joutchenko, L, Kavteladze, L, Bermejo, E, Martinez-Frias, M L, Gallagher, M, Erickson, J D, Vollset, S E, Mastroiacovo, P, Andria, G, Botto, L D (2003). Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J. Med. Genet. 40: 619-625 [Full Text]  
• Infante-Rivard, C, Levy, E, Rivard, G-E, Guiguet, M, Feoli-Fonseca, J-C (2003). Small babies receive the cardiovascular protective apolipoprotein {varepsilon}2 allele less frequently than expected. J. Med. Genet. 40: 626-629 [Full Text]  
• Shotelersuk, V, Ittiwut, C, Siriwan, P, Angspatt, A (2003). Maternal 677CT/1298AC genotype of the MTHFR gene as a risk factor for cleft lip. J. Med. Genet. 40: e64-64 [Full Text]  
• Kupferminc, M. J., Many, A., Lessing, J. B., Grandone, E., Margaglione, M., Infante-Rivard, C., Rivard, G.-E., Gauthier, R. (2002). Thrombophilia Polymorphisms and Intrauterine Growth Restriction. NEJM 347: 1530-1531 [Full Text]  
• Roberts, D., Schwartz, R. S. (2002). Clotting and Hemorrhage in the Placenta -- A Delicate Balance. NEJM 347: 57-59 [Full Text]